SCHEMBL9813152

SCHEMBL9813152

CCCC12CCC(=O)C=C1c1c(cc(OCC3=NCCN3)c(Cl)c1Cl)C2

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 5/20 0.45
ESR1 P03372 3/20 0.45
NISCH Q9Y2I1 8/20 0.38
ADRA1A P35348 3/20 0.38
HTR1A P08908 3/20 0.37
ADRA2A P08913 3/20 0.37
ADRA2B P18089 3/20 0.37
ADRA2C P18825 3/20 0.37
GRM2 Q14416 2/20 0.33
MEN1 O00255 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ADRA1D P25100 1/20 0.32
ADRA1B P35368 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7782054 0.83 ESR2 (0.49) ESR2ESR1GRM2MEN1ALOX15
SCHEMBL1885756 0.83 ESR2 (0.49) ESR2ESR1GRM2MEN1ALOX15
SCHEMBL1905793 0.82 ESR2 (0.45) ESR2ESR1GRM2MEN1ALOX15
SCHEMBL7786915 0.82 ESR2 (0.45) ESR2ESR1GRM2MEN1ALOX15
SCHEMBL7787597 0.82 ESR2 (0.45) ESR2ESR1GRM2MEN1ALOX15
SCHEMBL7791096 0.81 ESR2 (0.48) ESR2ESR1GRM2MEN1ALOX15
SCHEMBL1892357 0.81 ESR2 (0.48) ESR2ESR1GRM2MEN1ALOX15
SCHEMBL10529811 0.81 ESR2 (0.54) ESR2ESR1MEN1ALOX15TSHR
SCHEMBL1891390 0.80 ESR2 (0.46) ESR2ESR1GRM2HSD17B10
SCHEMBL7786874 0.80 ESR2 (0.46) ESR2ESR1GRM2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0217287-B1 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts MERCK & CO. INC. (US) 1991-06-26 EP claimed
EP-0217287-A2 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts MERCK & CO. INC. (US) 1987-04-08 EP claimed
EP-0217287-B1 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts MERCK & CO. INC. (US) 1991-06-26 EP disclosed
EP-0217287-A2 [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)-oxy]ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7yl)oxy]ethanimidic acid hydrazides, their derivatives and their salts MERCK & CO. INC. (US) 1987-04-08 EP disclosed
US-4604396-A TREATMENT OF GREY MATTER EDEMAS MERCK & CO., INC. (US) 1986-08-05 US disclosed